Biosimilars in rare diseases : a focus on paroxysmal nocturnal hemoglobinuria
Sign Up to like & getrecommendations! Published in 2022 at "Haematologica"
DOI: 10.3324/haematol.2022.281562
Abstract: Biologics, a class of medicines grown in and purified from genetically engineered cell cultures, have transformed the management of many cancers and rare diseases, such as paroxysmal nocturnal hemoglobinuria. As prescription drug spending has increased… read more here.
Keywords: nocturnal hemoglobinuria; paroxysmal nocturnal; biosimilars rare; rare diseases ... See more keywords